Alarming Cases of Cancer in Kenya: A case for Meru and Tharaka Nithi Counties
DOI:
https://doi.org/10.14738/bjhmr.101.13825Keywords:
Cancer; Kenya, Meru and Tharaka Nithi Counties; Prevalence; trends, risk factorsAbstract
Background: Cancer is one of the leading causes of morbidity and mortality worldwide. In Kenya, cancer as a disease ranks third as a cause of death after infectious and cardiovascular diseases and the cancer cases are increasing at an alarming rate. Objective: The current study was aimed at determining the prevalence trends of cancer in Meru and Tharaka Nithi Counties with an aim of putting proper infrastructural and human capacity development to combat cancer. Methods: A random selection of patients aged between five to eighty-two years clinically diagnosed as cancer patients who were visiting Meru and Chuka General Hospitals for a period of one year were recruited for the study. The participants were requested to give a verbal consent and respond to a brief questionnaire concerning their gender, age and the type of cancer they are suffering from. This study used retrogressive approach where the trend of cancer incidences and death rate were determined for the last eight years (2011 to 2018) using the hospital data. Data were analysed using statistical package for social sciences (SPSS). Results: This study established that the prevalence of cancer in people visiting hospitals in Meru and Tharaka Nithi Counties was 0.32% and 0.38% respectively. Further, the prevalence trends of cancer cases in the two counties have been increasing over the last eight years. Conclusion: The study concludes that cancer is prevalent in Meru and Tharaka Nithi Counties. It is therefore recommended that proper infrastructural and human capacity development be put in place to combat cancer.
References
Sarkar, Sibaji, Garrick Horn, Kimberly Moulton, Anuja Oza, Shannon Byler, Shannon Kokolus, and McKenna Longacre. "Cancer development, progression, and therapy: an epigenetic overview." International journal of molecular sciences 14, no. 10 (2013): 21087-21113.
World Health Organization (WHO).Cancer prevalence in Africa countries.Weekly Epidemiological Record 2019;PP 22-30.
Korir, Anne, Robai Gakunga, Sujha Subramanian, Nathan Okerosi, Gladys Chesumbai, Patrick Edwards, Florence Tangka et al. "Economic analysis of the Nairobi Cancer Registry: Implications for expanding and enhancing cancer registration in Kenya." Cancer epidemiology 45 (2016): S20-S29.
Hamilton, William. "Cancer diagnosis in primary care." British Journal of General Practice 60, no. 571 (2010):
Tenge, C. N., R. T. Kuremu, N. G. Buziba, K. Patel, and P. A. Were. "Burden and pattern of cancer in Western Kenya." East African medical journal 86, no. 1 (2009).
Kushi LH, Doyle C. Mccullough M. America cancer society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer JClin Med.2012; 62: 30-67.
Spechler SJ. Barrett esophagus and risk of Esophageal cancer: a clinical review. JAMA; 2013; 310: 627-636.
Kenya National Bureau of Statistics. Kenya population and housing census volume 1: Population by County and sub-County. Vol. I, Kenya National Bureau of Statistics. 2019. 1–38.
World Cancer Research Foundation International. Global cancer data by country. WCRF International, 2020. https://www.wcrf.org/cancer-trends/global-cancer-data-by-country/
Wenpeng Y, Maciej H. Cancer incidence increasing globally: The role of relaxed natural selection. Evol Appl.2019; 11(2): 140-152.
Allender S, Foster C, Hutchinson L, Arambepola C. (2020). Quantification of urbanization in relation to chronic diseases in developing countries: A systematic review. Journal of Urban Health.2020;85(6):938-951. 63
Mahshid G, Zahra P, Hamid S. Incidence, mortality and epidemiology of Breast cancer in the world. Asian Pac J Cancer.2021; 17(53): 43-6.
Doreen A, Vecchiola A, Aguirre B. and Villaseca P.Gynecological- endocological aspects in women carriers of BRCA 1/ 2 gene mutation.Climacteric.2019; 21(6): 529-515.
Vesna I, Natasha TR, Miroslav D. and Zora N Elevated plasma levels of Transforming Gowth Factor Beta-1 in patients with advanced breast cancer: Association with disease progression. Eur J Cancer.2021; 39(4): 454-61.
Narod SA. Personalized medicine and population health: Breast and ovarian cancer. Hum Genet.2020; 137(10):
Leslie B. The risk of Breast, Endometrial and Ovarian cancer in users of hormonal preparation.Basic ClinPharmacolToxicol.2021; 98(3): 288-96.
Prashanth R. Epidemiology of prostate cancer.World J Oncol; 2019; 10(2): 63-89.
Parlidis N, Stanta G, Audisio RA. Cancer prevalence and mortality in centenarians: a systematic review. Cvit Rev OncolHematol.2021; 83(1):145-152.
Daniel RS.Esophageal cancer male to female ratios in Africa: A systematic review and meta-analysis of geographic, time and age trends. Cancer Epidemiol.2021; 53: 119-128.
Courtenay WH. Behavioural factors associated with disease: Injury and death among men. Journal of men’s studies.2020; 9: 81-142.
Beyhan, C. and Aydin, C. (2021).Evaluation of coexistence of cancer and active tuberculosis; 16 case series.Respir Med Case Rep; 23:33-37.
White A, Johnson M. Men making sense of their chest pain- niggles, doubts and denials. J clinNurs; 2020; 9:
Muhammad F. Tobacco smoking and lung cancer.Sultan QaboosUniv Med J. 2019; 13(3): 345-358.
Somdatta P, Baridalyne N. Awareness of breast cancer in women of an urban resettlement colony. Indian J Cancer.2020; 45: 149-53.
Steven H. Impact on world history of the misdiagnosis of a cancer.Ann Clin Lab Sci.; 2020; 40(1): 88-9.
Lieberman D, Ladabaum U, Cruz C. Screening for colorectal cancer and evolving issues for physicians and patients: A review. JAMA.2021; 316: 2135-45.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Joshua Mutiso, Ciriaka Gitonga, Bulle Abdullahi, Jemimah Simbauni, Michael Gicheru
This work is licensed under a Creative Commons Attribution 4.0 International License.
